04012nam 2200613 a 450 991045933400332120200520144314.01-282-58491-X97866125849160-226-55179-210.7208/9780226551791(CKB)2670000000019430(EBL)534569(OCoLC)635292171(SSID)ssj0000422894(PQKBManifestationID)11310896(PQKBTitleCode)TC0000422894(PQKBWorkID)10432559(PQKB)10091588(StDuBDS)EDZ0000115688(MiAaPQ)EBC534569(DE-B1597)524681(DE-B1597)9780226551791(Au-PeEL)EBL534569(CaPaEBR)ebr10389542(CaONFJC)MIL258491(EXLCZ)99267000000001943020020712d2003 uy 0engur|n|---|||||txtccrMeasuring the gains from medical research[electronic resource] an economic approach /edited by Kevin M. Murphy and Robert H. TopelChicago University of Chicago Pressc20031 online resource (270 p.)Description based upon print version of record.0-226-55178-4 Includes bibliographical references and indexes.The health of nations: the contribution of improved health to living standards / William D. Nordhaus -- The economic value of medical research / Kevin M. Murphy and Robert Topel -- Pharmaceutical innovation, mortality reduction, and economic growth / Frank R. Lichtenberg -- The return to biomedical research: treatment and behavioral effects / David M. Cutler and Srikanth Kadiyala -- Biomedical research and then some: the causes of technological change in heart attack treatment / Paul Heidenreich and Mark McClellan -- Can medical cost-effectiveness analysis identify the value of research? / David Meltzer.In 1998, health expenditures in the United States accounted for 12.9% of national income-the highest share of income devoted to health in the developed world. The United States also spends more on medical research than any other country-in 2000, the federal government dedicated 8.4 billion to it, compared with only .7 billion for the entire European Union. In this book, leading health economists ask whether we are getting our money's worth. From an economic perspective, they find, the answer is a resounding "yes": in fact, considering the extraordinary value of improvements to health, we may even be spending too little on medical research. The evidence these papers present and the conclusions they reach are both surprising and convincing: that growth in longevity since 1950 has been as valuable as growth in all other forms of consumption combined; that medical advances producing 10% reductions in mortality from cancer and heart disease alone would add roughly 0 trillion-a year's GDP-to the national wealth; or that the average new drug approved by the FDA yields benefits worth many times its cost of development. The papers in this book are packed with these and many other surprising revelations, their sophisticated analysis persuasively demonstrating the massive economic benefits we can gain from investments in medical research. For anyone concerned about the cost and the value of such research-from policy makers to health care professionals and economists-this will be a landmark book.MedicineResearchCost effectivenessCongressesElectronic books.MedicineResearchCost effectiveness362.1/068Murphy Kevin M119818Topel Robert H145544MiAaPQMiAaPQMiAaPQBOOK9910459334003321Measuring the gains from medical research2288364UNINA